[Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy]

Lorenzo Monserrat1, Manuel Hermida, Beatriz Bouzas

  • 1Servicio de Cardiología del Hospital Juan Canalejo, A Coruña, Spain. Lorenzo_Monserrat@cannalejo.org

Insights

Familial dilated cardiomyopathy (DCM) is common in heart transplant recipients. Early signs like left ventricular enlargement and conduction defects may indicate familial disease.

Area of Science:

  • Cardiology
  • Genetics
  • Transplantation Medicine

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure requiring transplantation.
  • Understanding the genetic basis of DCM is crucial for risk stratification and family screening.

Purpose of the Study:

  • To determine the prevalence of familial DCM in heart transplant patients.
  • To characterize the clinical features and inheritance patterns of familial DCM.
  • To identify potential early markers for familial DCM.

Main Methods:

  • Studied 43 families with heart transplant recipients diagnosed with idiopathic DCM.
  • Excluded patients with a history of alcohol abuse.
  • Conducted clinical evaluations, ECGs, echocardiograms, blood tests, and DNA analysis in patients and relatives.

Main Results:

  • Familial DCM was identified in 25.6% of probands, and possible familial DCM in another 25.6%.
  • Fifteen relatives had DCM, 26 had left ventricular enlargement (LVE), and 5 had hypertrophic cardiomyopathy.
  • Autosomal dominant inheritance was most common, with some cases suggesting recessive inheritance and others showing conduction system defects.

Conclusions:

  • Familial DCM has a high prevalence in heart transplant candidates.
  • LVE, conduction abnormalities, and elevated creatine kinase may serve as early indicators of familial DCM.
  • Hypertrophic cardiomyopathy and familial DCM can be present even in patients with a prior diagnosis of alcoholic DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...